V. REFERENCES 



60. Kaplan, E.L.; Meier, P. (1958) Nonpara- 

 metric estimation from incomplete observations. 

 J. Am. Stat. Assoc. 53:457-481. 



61. Kramers, P.G.N. (1982) Studies on the induc- 

 tion of sex-linked recessive lethal mutations in 

 Drosophila melanogaster by nitroheterocyclic 

 compounds. Mutat. Res. 101:209-236. 



71. Maronpot, R.R., Boorman, G.A. (1982) Inter- 

 pretation of rodent hepatocellular proliferative 

 alterations and hepatocellular tumors in chemi- 

 cal safety assessment Toxicol Pathol 10:71-80 



72 Martin, W.J (1983) Nitrofurantoin: Evi- 

 dence for the oxidant injury of lung parenchymal 

 cells. Am. Rev. Respir Dis. 127:482-486. 



62. Kunin, CM. (1972) Antibiotic usage in pa- 

 tients with renal impairment. Hosp. Pract. 

 7:141-148. 



63. Kurokawa, Y.; Hayashi, Y ; Maekawa, A.; 

 Takahashi, M ; Kokubo, T.. Odashima, S. (1983) 

 Carcinogenicity of potassium bromate adminis- 

 tered orally to F344 rats. J. Natl Cancer Inst 

 71:965-971. 



64. Leskovac, V.; Popovic, M. (1980) .Vlechanism 

 of reduction of nitrofurantoin on liver micro- 

 somes. Pharmacol. Res Commun. 12:13-27 



65 Liedtke, R.K.; Ebel, S.; Missler, B.. Haase, 

 W ; Stein, L. (1980) Single dose pharmacokine- 

 tics of macrocrystalline nitrofurantoin formula- 

 tions. Arzneimittelforschung 30:833-836. 



73. Mason, R.P.; Holtzman, J.L. (1975a) The role 

 of catalytic superoxide formation in the O2 in- 

 hibition of nitroreductase. Biochem. Biophys. 

 Res. Commun. 67: 1267-1274. 



74. Mason, R.P ; Holtzman, J.L. (1975b) The 

 mechanism of microsomal and mitochondrial ni- 

 troreductase. Electron spin resonance evidence 

 for nitroaromatic free radical intermediates. 

 Biochemistry 14:1626-1632 



75. McCalla. DR. (1962) Chloroplasts of Eug- 

 lena gracilis affected by furadantin Science 

 137:225-226. 



76. McCalla, DR. ( 1965) Effect of nitrofurans on 

 the chloroplast system of Euglena gracilis. J. 

 Protozool. 12:34-41 



66. Linhart, M.S.; Cooper, J.; Martin, R.L.; Page, 

 N.; Peters, J. (1974) Carcinogenesis Bioassay 

 Data System. Comput Biomed Res. 7:230-248. 



77. McCalla, D R ; Voutsinos, D (1974) On the 

 mutagenicity of nitrofurans Mutat. Res. 26:3- 

 16. 



67. Lu, C; McCalla, DR., Bryant, D.W. (1979) 

 Action of nitrofurans on E. coli. Mutation and 

 induction and repair of daughter-strand gaps in 

 DNA. Mutat. Res. 67:133-144. 



68. Maiti, T.K.; Banerjee, S. (1978). Intestinal 

 absorption of nitrofurantoin. Indian J Exp 

 Biol. 16:360-362. 



69. Mantel, N.; Haenszel, W. (1959) Statistical 

 aspects of the analysis of data from retrospective 

 studies of disease. J. Natl. Cancer Inst. 22:719- 

 748. 



70. Margolin, B H ; Collings, B.J.; Mason, J.M. 

 (1983) Statistical analysis and sample-size de- 

 terminations for mutagenicity experiments with 

 binomial responses. Environ. Mutagen 5:705- 

 716. 



78. McCarroU, N E.; Keech, BH.; Piper, C.E. 

 (1981) A microsuspension adaptation of the Ba- 

 cillus subtilis "rec" assay. Environ. Mutagen. 

 3:607-616. 



79. McConnell, E.E.; SoUeveld, H.A.; Swenberg, 

 J. A.; Boorman, G.A. (1986) Guidelines for com- 

 bining neoplasms for evaluation of rodent car- 

 cinogenesis studies. J. Natl. Cancer Inst. 

 76:283-289. 



80. Meyer, M.C.; Slywka, G W A.; Dann, RE.; 

 Whyatt, P.L. (1974) Bioavailability of 14 nitro- 

 furantoin products J Pharm. Sci. 63:1693- 

 1698. 



81. Montemurro, D G. (1969) The effect of nitro- 

 furazone on the testes and accessory sex organs 

 of normal rats and rats bearing the Walker car- 

 cinoma 256. Br J Cancer 14:319-326. 



71 



Nitrofurantoin, NTP TR 341 



